Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation.

Karen Hale, who joined Novartis in 2021 as chief legal officer, will take on the new chief legal and compliance officer role.

Basel: Novartis has announced the appointment of Karen Hale to the expanded role of Chief Legal and Compliance Officer for ...

Novartis announced today the appointment of Karen Hale to the expanded role of Chief Legal and Compliance Officer for Novartis, effective April 14, 2025. She will continue to report to Vas Narasimhan, ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

With the conclusion of the China Development Forum (CDF), one of the country's major international event, China ushers in its ...

BEIJING, March 25 (Xinhua) -- Chinese Vice President Han Zheng met with John Swire & Sons Limited CEO Merlin Swire and Novartis CEO Vas Narasimhan on Monday in Beijing, who are here for the China ...

To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as ...

Commenting on Novartis’ latest quarterly earnings, CEO Vas Narasimhan said, “In our first full year as a pure-play innovative medicines company, Novartis delivered one of the strongest ...

Swiss pharmaceutical giant Novartis (SIX:NOVN) is keeping a close eye on the U.S. tariff policy proposed by the Biden administration, which could impose a 25% import duty on pharmaceuticals. Speaking ...